Alaa Shammah, MD
Sleep Medicine · Indianapolis, INNPI 1932514999
Payments from drug & device makers
What this record shows
Inspire Medical Systems, Inc. accounts for 74.4% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $2,762 and has fallen 94.0% since, to $166 in 2025.
Across 49 payments — averaging $70.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$3K
- Johnson & Johnson$357
- Jazz Pharmaceuticals Inc.$125
- AbbVie$89
- Axsome Therapeutics, Inc.$70
- Harmony Biosciences LLC$48
- plus $189 from 6 others
What the payments were for
- Travel & lodging$1,66048%
- Food & beverage$1,77552%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 18 | $2,556 |
| Johnson & Johnson | 9 | $357 |
| Jazz Pharmaceuticals Inc. | 1 | $125 |
| AbbVie(2 entities) | 4 | $89 |
| Axsome Therapeutics, Inc. | 4 | $70 |
| Harmony Biosciences LLC | 3 | $48 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $48 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $44 |
| Resmed Corp | 2 | $35 |
| Medtronic | 1 | $30 |
| Novartis | 1 | $17 |
| ZOLL Respicardia, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,435 in reported general payments places this provider in the 80th percentile of 32 sleep medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 12 | $161 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Indianapolis
- Shalini ManchandaIndianapolis$43K
- Adam LenetIndianapolis$5K
- Joshua BarzilaiIndianapolis$2K
- Anil AchaenIndianapolis$2K
- Yuzhu TangIndianapolis$1K
- Tarek DabboussiIndianapolis$1K
- Stephanie StahlIndianapolis$667
- Rohan ThompsonIndianapolis$509
- Anita RajagopalIndianapolis$282
- Milton Marvin ChuaIndianapolis$110
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.